WHWK
Whitehawk Therapeutics, Inc. (WHWK)
Market Closed
15 Dec, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
2. 35
+0.03
+1.29%
$
- Market Cap
- P/E Ratio
- Div Yield
99,006 Volume
- Eps
$ 2.32
Previous Close Day Range
2.3 2.44
Year Range
1.39 3.81
Want to track WHWK and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Whitehawk Therapeutics Inc. (WHWK) Q4 2024 Earnings Call Transcript
Whitehawk Therapeutics Inc. (NASDAQ:WHWK ) Q4 2024 Results Conference Call March 19, 2025 8:30 AM ET Company Participants Audrey Gross - Head of Corporate Communications Dave Lennon - President and Chief Executive Officer Scott Giacobello - Chief Financial Officer, Investor Relations and Corporate Communications David Dornan - Chief Scientific Officer Conference Call Participants Greg Weasner - TD Securities Liang Cheng - Jefferies Operator Ladies and gentlemen, thank you for standing by. Welcome to Whitehawk Therapeutics Fourth Quarter and Full Year 2024 Earnings Call.
Seekingalpha | 9 months ago
2025 © Marketlog. All Rights Reserved.
